PACT Feasibility Study for Cardiovascular Risk After Cancer
This study is testing a new "Clinical Decision Aid" tool to help cancer survivors and their heart doctors make better decisions about preventing heart problems. The tool will be used during regular cardiology (heart doctor) visits. You might be able to join if you are 18 or older, have a history of cancer, haven't seen a heart doctor for your cancer-related heart risk before, and are considered at intermediate, high, or very high risk for heart disease. The researchers want to see if using this tool leads to more appropriate medication use and heart imaging. They will consider the study successful if at least 85% of visits using the tool result in recommended medication use and imaging, and if patients and doctors have positive feedback. The current recruitment status is unclear.
- Study design
- This is an observational study with 60 participants. It is a single-center, double-arm, open-label, randomized feasibility study.
- What's involved
- You would have cardiology clinic visits at Week 0, Week 12, and Week 24. The Clinical Decision Aid tool will be used at these visits.
- Compensation
- Not stated in the trial record.
- Follow-up
- Participants are followed for 24 weeks, with medication use measured at Week 0, Week 12, and Week 24.
AI-generated from the public study record. Only the study team can confirm whether you're eligible — confirm details with them before making decisions.
PAtient Similarity for Decision-Making in Prevention of Cardiovascular Toxicity (PACT): A Feasibility Study
At a glance
Conditions
Where it's being run
1 sites across 1 statesStudy leadership
- Yee Chung Cheng, MD · PRINCIPAL_INVESTIGATOR · Medical College of Wisconsin
Who to contact
Opens a ready-to-send draft in your own email app — review before sending.
What this trial measures
- Medication useWeek 0
The number of subjects in which medication use pursued is consistent with current medical society recommendations appropriate for the subject.
- Medication useWeek 12
The number of subjects in which medication use pursued is consistent with current medical society recommendations appropriate for the subject.
- Medication useWeek 24
The number of subjects in which medication use pursued is consistent with current medical society recommendations appropriate for the subject.
- Imaging surveillanceWeek 0
The number of subjects in which imaging surveillance pursued is consistent with current medical society recommendations appropriate for the subject.
- Imaging surveillanceWeek 12
The number of subjects in which imaging surveillance pursued is consistent with current medical society recommendations appropriate for the subject.
- Imaging surveillanceWeek 24
The number of subjects in which imaging surveillance pursued is consistent with current medical society recommendations appropriate for the subject.